Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value ($000): $1,236,066 (98.2% shares, 1.8% debt)

Holdings (15)

VTI VANGUARD INDEX FDS 25.5%

Value ($000) $315,785 Shares 2,979,100 Est. Cost $57.39 Unrealized —

— OPHTHOTECH CORP 21.4%

Value ($000) $264,815 Shares 5,901,819 Est. Cost $32.35 Unrealized —

INGN INOGEN INC 9.0%

Value ($000) $111,342 Shares 3,549,320 Est. Cost $17.78 Unrealized +36.3%

VGK VANGUARD INTL EQUITY INDEX F 8.9%

Value ($000) $110,113 Shares 2,101,000 Est. Cost $45.01 Unrealized —

— ALDER BIOPHARMACEUTICALS INC 7.5%

Value ($000) $93,122 Shares 3,201,183 Est. Cost $20.07 Unrealized —

— NEVRO CORP 6.9%

Value ($000) $84,875 Shares 2,194,841 Est. Cost $38.67 Unrealized —

— OTONOMY INC 5.9%

Value ($000) $72,494 Shares 2,175,025 Est. Cost $24.00 Unrealized —

— TETRAPHASE PHARMACEUTICALS INC 4.7%

Value ($000) $58,572 Shares 1,475,000 Est. Cost $23.73 Unrealized —

— FLEXION THERAPEUTICS INC 3.7%

Value ($000) $46,096 Shares 2,283,131 Est. Cost $17.27 Unrealized —

— Wright Medical Group 1.8%

Value ($000) $22,562 Shares 4,720,065 Est. Cost $2.50 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 1.4%

Value ($000) $17,651 Shares 1,516,387 Est. Cost $24.08 Unrealized -40.4%

— TOKAI PHARMACEUTICALS INC 1.4%

Value ($000) $17,378 Shares 1,178,992 Est. Cost $14.46 Unrealized —

— AERIE PHARMACEUTICALS INC 1.0%

Value ($000) $12,250 Shares 419,652 Est. Cost $29.19 Unrealized —

— INTERSECT ENT INC 0.5%

Value ($000) $6,492 Shares 350,000 Est. Cost $15.50 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.2%

Value ($000) $2,519 Shares 127,563 Est. Cost $14.68 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,979,100	$315,785	25.5%	$57.39	—	TOTAL STK MKT	922908769
—	OPHTHOTECH CORP	5,901,819	$264,815	21.4%	$32.35	—	COM	683745103
INGN	INOGEN INC	3,549,320	$111,342	9.0%	$17.78	+36.3%	COM	45780L104
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$110,113	8.9%	$45.01	—	FTSE EUROPE ETF	922042874
—	ALDER BIOPHARMACEUTICALS INC	3,201,183	$93,122	7.5%	$20.07	—	COM	014339105
—	NEVRO CORP	2,194,841	$84,875	6.9%	$38.67	—	COM	64157F103
—	OTONOMY INC	2,175,025	$72,494	5.9%	$24.00	—	COM	68906L105
—	TETRAPHASE PHARMACEUTICALS INC	1,475,000	$58,572	4.7%	$23.73	—	COM	88165N105
—	FLEXION THERAPEUTICS INC	2,283,131	$46,096	3.7%	$17.27	—	COM	33938J106
—	Wright Medical Group	4,720,065	$22,562	1.8%	$2.50	—	Contingent Value Rights	98235T115
AKBA	AKEBIA THERAPEUTICS INC	1,516,387	$17,651	1.4%	$24.08	-40.4%	COM	00972D105
—	TOKAI PHARMACEUTICALS INC	1,178,992	$17,378	1.4%	$14.46	—	COM	88907J107
—	AERIE PHARMACEUTICALS INC	419,652	$12,250	1.0%	$29.19	—	COM	00771V108
—	INTERSECT ENT INC	350,000	$6,492	0.5%	$15.50	—	COM	46071F103
XENE	XENON PHARMACEUTICALS INC	127,563	$2,519	0.2%	$14.68	0.0%	COM	98420N105